113 related articles for article (PubMed ID: 12137195)
1. Virolytic action of lipoprotein lipase on hepatitis C virus in human sera.
Thomssen R; Bonk S
Med Microbiol Immunol; 2002 May; 191(1):17-24. PubMed ID: 12137195
[TBL] [Abstract][Full Text] [Related]
2. Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III.
Sun HY; Lin CC; Lee JC; Wang SW; Cheng PN; Wu IC; Chang TT; Lai MD; Shieh DB; Young KC
Gut; 2013 Aug; 62(8):1193-203. PubMed ID: 22689516
[TBL] [Abstract][Full Text] [Related]
3. Association of hepatitis C virus in human sera with beta-lipoprotein.
Thomssen R; Bonk S; Propfe C; Heermann KH; Köchel HG; Uy A
Med Microbiol Immunol; 1992; 181(5):293-300. PubMed ID: 1335546
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein lipase inhibits hepatitis C virus (HCV) infection by blocking virus cell entry.
Maillard P; Walic M; Meuleman P; Roohvand F; Huby T; Le Goff W; Leroux-Roels G; Pécheur EI; Budkowska A
PLoS One; 2011; 6(10):e26637. PubMed ID: 22039521
[TBL] [Abstract][Full Text] [Related]
5. Density heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins.
Thomssen R; Bonk S; Thiele A
Med Microbiol Immunol; 1993 Dec; 182(6):329-34. PubMed ID: 8121333
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein lipase mediates hepatitis C virus (HCV) cell entry and inhibits HCV infection.
Andréo U; Maillard P; Kalinina O; Walic M; Meurs E; Martinot M; Marcellin P; Budkowska A
Cell Microbiol; 2007 Oct; 9(10):2445-56. PubMed ID: 17517063
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein lipase liberates free fatty acids to inhibit HCV infection and prevent hepatic lipid accumulation.
Sun HY; Lin CC; Tsai PJ; Tsai WJ; Lee JC; Tsao CW; Cheng PN; Wu IC; Chiu YC; Chang TT; Young KC
Cell Microbiol; 2017 Apr; 19(4):. PubMed ID: 27665576
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein lipase and hepatic triglyceride lipase reduce the infectivity of hepatitis C virus (HCV) through their catalytic activities on HCV-associated lipoproteins.
Shimizu Y; Hishiki T; Sugiyama K; Ogawa K; Funami K; Kato A; Ohsaki Y; Fujimoto T; Takaku H; Shimotohno K
Virology; 2010 Nov; 407(1):152-9. PubMed ID: 20822787
[TBL] [Abstract][Full Text] [Related]
9. High-density lipoprotein binding rate differs greatly between genotypes 1b and 2a/2b of hepatitis C virus.
Kono Y; Hayashida K; Tanaka H; Ishibashi H; Harada M
J Med Virol; 2003 May; 70(1):42-8. PubMed ID: 12629642
[TBL] [Abstract][Full Text] [Related]
10. Characterization of low- and very-low-density hepatitis C virus RNA-containing particles.
André P; Komurian-Pradel F; Deforges S; Perret M; Berland JL; Sodoyer M; Pol S; Bréchot C; Paranhos-Baccalà G; Lotteau V
J Virol; 2002 Jul; 76(14):6919-28. PubMed ID: 12072493
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus RNA in blood donor sera detected by the polymerase chain reaction: comparison with supplementary hepatitis C antibody assays.
Widell A; Månsson AS; Sundström G; Hansson BG; Nordenfelt E
J Med Virol; 1991 Dec; 35(4):253-8. PubMed ID: 1724983
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus RNA in patients with anti-HCV on hemodialysis. Relationship to transaminase levels.
Garcia-Valdecasas J; Bernal C; Cerezo S; Garcia F; Montiel N; Leyva A; Umana WO; Bosch JP
ASAIO J; 1994; 40(3):M450-3. PubMed ID: 8555556
[TBL] [Abstract][Full Text] [Related]
13. Testing of corneoscleral discs and their culture media of seropositive donors for hepatitis B and C virus genomes.
Sengler U; Reinhard T; Adams O; Gerlich W; Sundmacher R
Graefes Arch Clin Exp Ophthalmol; 2001 Oct; 239(10):783-7. PubMed ID: 11760041
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus infection in sporadic fulminant viral hepatitis in North India: cause or co-factor?
Jain A; Kar P; Madan K; Das UP; Budhiraja S; Gopalkrishna V; Sharma JK; Das BC
Eur J Gastroenterol Hepatol; 1999 Nov; 11(11):1231-7. PubMed ID: 10563532
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin G and M hepatitis C virus core antibody (JCC.2) response in chimpanzees infected experimentally with hepatitis C virus.
Shioda A; Moriyama M; Hayashi N; Sugitani M; Uchida T; Shikata T; Nishizono A; Abe K; Arakawa Y
Intervirology; 2000; 43(3):146-53. PubMed ID: 11044808
[TBL] [Abstract][Full Text] [Related]
16. Visualization of hepatitis C virions and putative defective interfering particles isolated from low-density lipoproteins.
Prince AM; Huima-Byron T; Parker TS; Levine DM
J Viral Hepat; 1996 Jan; 3(1):11-7. PubMed ID: 8736235
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C.
Pham TN; MacParland SA; Mulrooney PM; Cooksley H; Naoumov NV; Michalak TI
J Virol; 2004 Jun; 78(11):5867-74. PubMed ID: 15140984
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus antibody detection by a line immunoassay and (near) full length genomic RNA detection by a new RNA-capture polymerase chain reaction.
van Doorn LJ; van Belkum A; Maertens G; Quint W; Kos T; Schellekens H
J Med Virol; 1992 Dec; 38(4):298-304. PubMed ID: 1282148
[TBL] [Abstract][Full Text] [Related]
19. The majority of lipoprotein lipase in plasma is bound to remnant lipoproteins: A new definition of remnant lipoproteins.
Sato K; Okajima F; Miyashita K; Imamura S; Kobayashi J; Stanhope KL; Havel PJ; Machida T; Sumino H; Murakami M; Schaefer E; Nakajima K
Clin Chim Acta; 2016 Oct; 461():114-25. PubMed ID: 27342999
[TBL] [Abstract][Full Text] [Related]
20. A precipitation reaction found in patients with hepatitis C as a marker for the purification of virus-like particles.
Kim CY; Yoon J; Kim JS; Kim YT; Jung HC; Lee H; Yoon YB; Song IS
Intervirology; 1999; 42(4):263-70. PubMed ID: 10567845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
